Last updated: July 28, 2023
Sponsor: Zhongda Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
CXCL2/CXCL8
Clinical Study ID
NCT05976516
20220224016
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- It meets the diagnostic criteria of lumbar disc degeneration; No previous history ofspinal surgery; Good ability of independent behavior and cooperation in completingresearch; The patient is aware of this study and has signed the consent form.
Exclusion
Exclusion Criteria:
- Patients with spinal tumor, infection, tuberculosis and other diseases; Patients withclaustrophobia; Parkinson's syndrome patients; Poor cooperation, Poor image quality;Patients with osteoporosis.
Study Design
Total Participants: 40
Treatment Group(s): 1
Primary Treatment: CXCL2/CXCL8
Phase:
Study Start date:
August 01, 2023
Estimated Completion Date:
March 30, 2024
Connect with a study center
Zhongda Hospital
Nanjing, Jiangsu
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.